Upon completion of this activity, the learner will be able to:
- Describe current statistics related to polycystic ovary syndrome.
- Defi ne and describe key features of polycystic ovary syndrome.
- Discuss the current evidence surrounding different treatment strategies for symptoms of polycystic ovary syndrome.
The authors and planners of this activity report no conficts of interest or relevant financial relationships. This article includes discussion of the off-label use of the following drugs: finasteride, flutamide, metformin, letrozole, orlistat, pioglitazone, spironolactone and tamoxifen. No commercial support was received for this learning activity.
Continuing Nursing Education (CNE) Credit
A total of 1 contact hour may be earned as CNE credit for reading “Polycystic Ovary Syndrome: Evidence-based Strategies for Managing Symptoms and Preventing Long-Term Sequelae” and for completing an online post-test and participant feedback form.
To take the test and complete the participant feedback form, please visit http://JournalsCNE.awhonn.org. Certificates of completion will be issued on receipt of the completed participant feedback form and processing fees.
AWHONN is accredited as a provider of continuing nursing education by the American Credentialing Center's Commission on Accreditation.
Accredited status does not imply endorsement by AWHONN or ANCC of any commercial products displayed or discussed in conjunction with an educational activity.
AWHONN also holds a California BRN number California CNE provider #CEP580.